Towards Mechanism-Based Treatments for Fragile X Syndrome
Section on Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
Author to whom correspondence should be addressed.
Received: 13 August 2019 / Accepted: 14 August 2019 / Published: 16 August 2019
PDF [185 KB, uploaded 16 August 2019]
Note: In lieu of an abstract, this is an excerpt from the first page.
Fragile X syndrome (FXS) is the most common heritable form of intellectual disability, as well as the most common known monogenic cause of autism spectrum disorder (ASD), affecting 1 in 4000–8000 people worldwide [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Kumari, D.; Gazy, I. Towards Mechanism-Based Treatments for Fragile X Syndrome. Brain Sci. 2019, 9, 202.
Kumari D, Gazy I. Towards Mechanism-Based Treatments for Fragile X Syndrome. Brain Sciences. 2019; 9(8):202.
Kumari, Daman; Gazy, Inbal. 2019. "Towards Mechanism-Based Treatments for Fragile X Syndrome." Brain Sci. 9, no. 8: 202.
Show more citation formats
Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.